How severe is CVE-2018-14786?

CVE-2018-14786 has a CVSS 3.x base score of 9.4, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity high, and availability high.

Is CVE-2018-14786 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (86th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2018-14786?

CVE-2018-14786 primarily affects Bd Alaris Gs Firmware. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2018-14786?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2018-14786 published?

CVE-2018-14786 was published on 2018-08-23 and last updated on 2026-06-17.

CVE-2018-14786

CVE-2018-14786 is a critical-severity vulnerability in Bd Alaris Gs Firmware with a CVSS 3.x base score of 9.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Severity: Critical (CVSS 3.x base score 9.4)
CVSS v2: 7.5
EPSS exploit prediction: 3% (86th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-287
Affected product: Bd Alaris Gs Firmware
Published: 2018-08-23
Last modified: 2026-06-17

Description

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Frequently asked questions

What is CVE-2018-14786?: Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
How severe is CVE-2018-14786?: CVE-2018-14786 has a CVSS 3.x base score of 9.4, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity high, and availability high.
Is CVE-2018-14786 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (86th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2018-14786?: CVE-2018-14786 primarily affects Bd Alaris Gs Firmware. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2018-14786?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2018-14786 published?: CVE-2018-14786 was published on 2018-08-23 and last updated on 2026-06-17.

References

Affected products (4)

cpe:2.3:o:bd:alaris_gs_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:bd:alaris_gh_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:bd:alaris_cc_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:bd:alaris_tiva_firmware:*:*:*:*:*:*:*:*

Other CWE-287 (Improper Authentication) vulnerabilities

CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…

Browse all CWE-287 (Improper Authentication) vulnerabilities →